-- U.S. RESEARCH ROUNDUP-Twitter Inc, Intercept Pharmaceuticals 
-- 
-- Wed Jul 30, 2014 03:10AM EDT
-- None



July 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Intercept Pharmaceuticals and Twitter, on Wednesday.

HIGHLIGHTS * Twitter Inc <TWTR.N>: Pivotal Research cuts to sell; RBC, Evercore raise price target  * Diana Shipping Inc <DSX.N>: Stifel raises to buy from hold * Intercept Pharmaceuticals <ICPT.O>: Nomura raises to buy from neutral; target to $323   Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.   * AK Steel <AKS.N>: Nomura raises target price to $7 from $6; rating neutral * Aflac Inc <AFL.N>: RBC cuts target price to $65 from $66; rating sector perform * American Express <AXP.N>: SunTrust raises target price to $100 from $98; rating buy * Anadarko Petroleum Corp <APC.N>: Stifel raises target price to $128 from $110; rating buy * Arrow Electronics Inc <ARW.N>: UBS raises target price to $59 from $55; rating neutral * Diana Shipping Inc <DSX.N>: Stifel raises to buy from hold * Digital Realty Trust <DLR.N>: MLV & Co raises price target to $64 from $60; rating hold * Digital Realty Trust <DLR.N>: Canaccord raises target price to $62 from $60; rating hold * Discovery Communications <DISCA.O>: Evercore raises target to $90 from $84; equal-weight * Dyax Corp <DYAX.O>: Leerink raises price target to $8 from $7; rating market perform * Equity Residential <EQR.N>: ISI Group raises price target by $3 to $67; rating neutral * Exactech Inc <EXAC.O>: Canaccord Genuity raises target price to $32 from $31; rating buy * Express Scripts <ESRX.O>: Jefferies cuts target price to $80 from $86; rating buy * Galectin Therapeutics <GALT.O>: MLV & Co cuts target price to $16 from $27; rating buy * Global Payments <GPN.N>: Evercore raises price target by $8 to $79; rating equal-weight * Harris Corp <HRS.N>: JP Morgan raises target price to $64 from $60; rating underweight * Headwaters Inc <HW.N>: Canaccord Genuity cuts target price to $14 from $15; rating buy * Intercept Pharmaceuticals <ICPT.O>: Nomura raises to buy from neutral * Intercept Pharmaceuticals <ICPT.O>: Nomura raises target price to $323 from $294 * ITW <ITW.N>: Morgan Stanley raises target price to $85 from $83; rating underweight * Level 3 Communications <LVLT.N>: Canaccord raises target price to $55 from $50; rating buy * Medidata Solutions <MDSO.O>: Jefferies raises target price to $53 from $50; rating buy * MMC <MMC.N>: Nomura raises target price to $54 from $49; rating neutral * National Oilwell Varco <NOV.N>: SocGen raises target price to $95 from $93; rating buy * NCR Corp <NCR.N>: Wedbush cuts target price to $31 from $32; rating neutral * Oplink Communications <OPLK.O>: B.Riley raises target price to $23 from $21; rating buy * Oshkosh Corp <OSK.N>: Jefferies cuts target price to $55 from $66; rating buy * PartnerRe <PRE.N>: Nomura raises target price to $108 from $105; rating neutral * Rubicon Project Inc <RUBI.N>: RBC cuts target price to $15 from $19; rating outperform * Scripps Networks <SNI.N>: Evercore raises target to $89 from $80; rating equal-weight * Twitter Inc <TWTR.N>: Evercore raises price target to $55 from $48; rating overweight * Twitter Inc <TWTR.N>: Pivotal Research cuts to sell from hold * Twitter Inc <TWTR.N>: Pivotal Research raises target price to $38 from $37 * Twitter Inc <TWTR.N>: RBC raises target price to $65 from $60; rating outperform * Ultimate Software <ULTI.O>: Canaccord raises target price to $155 from $150; rating buy * United Therapeutics <UTHR.O>: Credit Suisse raises target to $100 from $75; rating neutral